2010 IPO
InVivo Therapeutics Stock
InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.
Sign up today and learn more about InVivo Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About InVivo Therapeutics Stock
InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of research initiated in the laboratories of Robert Langer, PhD, of the Massachusetts Institute of Technology, Jay Vacanti, MD, of the Massachusetts General and Children’s Hospitals in Boston, and Yang Teng, PhD, MD, of Harvard's Brigham and Women's Hospital.
Funding History
| December 2010 | $13.0M |
|---|---|
| October 2011 | $30.0M |
| March 2016 | $32.2M |
| January 2018 | $15.2M |
Management
CFO
Sean Moran
Director
Kenneth DiPietro
Chief Scientific Officer
Thomas R. Ulich
Director/Non-Executive Chairman of the Board
John A. McCarthy, Jr.
President,CEO & CMO
Richard Toselli
Chief Medical Officer
Lou Vaickus
Interim CFO
Steven F. McAllister
Chief Technology Officer
Brian Hess
Vice President, Business Development
Christopher McNulty
Chief Science Officer
Christopher Pritchard
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
